Opyl Ltd. is an information technology company, which engages in the development of digital tools that improve the healthcare experience for patients, deliver deep market insights from social media data, and improve the efficiency and value of clinical research process. Its services Opin-Clinical Trial Recuitment platform created by Opyl that leverages social media, search engine optimization technologies, and emerging artificial intelligence science, matching patients directly to clinical trials. The company was founded by Marc Angelone and Noah Abelson-Gertleron on January 17, 1994 and is headquartered in St. Kilda, Australia.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company